Jason L Freedman, MD, MSCE

Assistant Professor of Clinical Pediatrics
Attending Physician, Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA
Course Director, Cellular Therapy + Transplant Educational Series, Children's Hospital of Philadelphia, Philadelphia, PA
Director, Hospitalist Program in Oncology/BMT, Children's Hospital of Philadelphia, Philadelphia, PA
Director, Pediatric Residency Oncology Rotation, Children's Hospital of Philadelphia, Philadelphia, PA
Inpatient Medical Director, Oncology/BMT, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of Oncology, HUB 3523
3501 Civic Center Boulevard
Philadelphia, PA 19104
Division of Oncology, HUB 3523
3501 Civic Center Boulevard
Philadelphia, PA 19104
Email:
freedmanj@chop.edu
freedmanj@chop.edu
Publications
Education:
BS
Cornell University, 2002.
MD
State University of NY Upstate Medical University, 2006.
MSCE
University of Pennsylvania, 2013.
Permanent linkBS
Cornell University, 2002.
MD
State University of NY Upstate Medical University, 2006.
MSCE
University of Pennsylvania, 2013.
Description of Clinical Expertise
Pediatric Stem Cell TransplantationPediatric Oncology
Pediatric Supportive Care
Description of Other Expertise
Medical Director & Inpatient AdministrationHospitalist Medicine in Pediatric Hematology/Oncology
Quality Improvement in Pediatric Oncology
Description of Research Expertise
Clinical Trials in Pediatric Supportive CareEpidemiologic studies in Supportive Care
Selected Publications
Roth E, Reahm D, D'Aprile A, Freedman JL, Grupp S, Wang Y: Infusing Collaboration: Stem Cell Infusion Day Procedure. Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, Orlando, Florida (Accepted for Poster presentation) February 2023.Wohlschlaeger Anne, Levy E, Khan R, Heimall J, Fisher Bm Metjian T, Elgarten C, Freedman J: A Retrospective Review of Revaccination Patterns in Pediatric Hematopoietic Stem Cell Transplant Recipients. Journal of Pediatric Hematology/Oncology Nursing 2023 Notes: Accepted for publication.
Schuster JE, Hamdan L, Dulek D, Kitco CL, Batarseh E, Haddadin Z, Stewart L, Stahl A, Potter M, Rahman H, Kalams S, Coffin S, Ardura M, Wattier R, Maron G, Bocchini C, Moulton E, Grimley M, Paulsen G, Harrison C, Freedman J, Carpenter P, Englund J, Munoz F, Danziger-Isakov L, Spieker A, Halasa N for the Pediatric HCT Flu Study. : Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients. New England Journal of Medicine 2023 Notes: Accepted for publication.
Kerman C, Freedman J: Acute complications of cancer therapy. Caring for the Hospitalized Child: 3rd Edition - A Handbook of Inpatient Pediatrics. Rauch DA and Gershel JC (eds.). 2023.
Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA.: Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL). A Report from the Children’s Oncology Group (COG) Trial AALL1231 (Poster Presentation), American Society of Hematology (ASH), New Orleans, LA December 2022.
Jones TM, Madden R, Tugh L, Hochter N, Yeager M, Fooks Parker S, Fierson A, Smith L, Davis K, Freedman JL.: Adaptation and Acceptability of Token Economy Shown to Improve Adherence to Activities of Daily Living in Pediatric Hematopoietic Stem Cell Transplant (Poster Presentation). International Society of Paediatric Oncology (SIOP), Barcelona, Spain. October 2022.
Davidow K, Bunin N, Goldfarb S, Li Y, Freedman JL. : Pulmonary Outcomes After Autologous Stem Cell Transplant for Hodgkin Lymphoma. Journal of Pediatric Hematology/Oncology 44(6): e926-e929, Aug 2022 Notes: doi: 10.1097/MPH.0000000000002301.
Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, Annett RD, Archer JH, Asselin BL, August KJ, Cho SY, Dunsmore KP, Fisher BT, Freedman JL, Galardy PJ, Harker-Murray P, Horton TM, Jaju AI, Lam A, Messinger YH, Miles RR, Okada M, Patel SI, Schafer ES, Schechter T, Singh N, Steele AC, Sulis ML, Vargas SL, Winter SS, Wood C, Zweidler-McKay P, Bollard CM, Loh ML, Hunger SP, Raetz EA.: Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma. Journal of Clinical Oncology 40(19): 2106 - 2118, July 2022 Notes: doi: 10.1200/JCO.21.02678.
Bercovitz, I., Woodard, K.N., Freedman, J.L., Gross, J.Y., Poliakova, P., Venella, K., Barakat, L.P., and Daniel, L.C.: Comparison of Sleep-Related Impairments and Disturbances: Pediatric Hematopoietic Stem Cell Transplant (HSCT) Inpatients and Oncology Outpatients (Poster & Oral Presentation). Multinational Association of Supportive Care in Cancer (MASCC) Annual Conference, Toronto CA June 2022.
Devine KJ, Diorio C, Richman SA, Henderson AA, Oranges K, Armideo E, Kolb MS, Freedman JL, Aplenc R, Fisher MJ, Minturn JE, Olson T, Bagatell R, Barakat L, Croy C, Mauro J, Vitlip L, Acord MR, Mattei P, Johnson VK, Devine CM, Pasquariello C, Reilly AF.: Guideline for Children With Cancer Receiving General Anesthesia for Procedures and Imaging. Journal of Pediatric Hematology/Oncology 44(4): e859 - e865, May 2022 Notes: doi: 10.1097/MPH.0000000000002430.